These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TGF beta signalling and its role in tumour pathogenesis. Kaminska B; Wesolowska A; Danilkiewicz M Acta Biochim Pol; 2005; 52(2):329-37. PubMed ID: 15990918 [TBL] [Abstract][Full Text] [Related]
6. Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models. Xiao H; Zhang YY Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):335-41. PubMed ID: 18290874 [TBL] [Abstract][Full Text] [Related]
7. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Levy L; Hill CS Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta and Smad signalling in kidney diseases. Wang W; Koka V; Lan HY Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of TGFβ signaling and its implications in anticancer treatments. Calone I; Souchelnytskyi S Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142 [TBL] [Abstract][Full Text] [Related]
17. HtrA proteins as targets in therapy of cancer and other diseases. Zurawa-Janicka D; Skorko-Glonek J; Lipinska B Expert Opin Ther Targets; 2010 Jul; 14(7):665-79. PubMed ID: 20469960 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of drug inhibition of signalling molecules. Sebolt-Leopold JS; English JM Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058 [TBL] [Abstract][Full Text] [Related]